Pharmaceutical Executive cover image

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Pharmaceutical Executive

00:00

Regeneron–Tessera $150M Gene Editing Deal

Unknown Host reports on Regeneron's $150 million collaboration with Tessera to advance RNA-based gene writing platforms.

Play episode from 00:30
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app